查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813837

智慧吸入器市场规模、份额和趋势分析报告：按类型、适应症、分销管道、最终用途、地区和细分市场预测，2025 年至 2033 年

Smart Inhalers Market Size, Share & Trends Analysis Report By Type (Dry Powdered Inhalers, Metered Dose Inhalers), By Indication (Asthma, Pulmonary Disease), By Distribution Channel, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

智慧吸入器市场摘要

预计 2024 年全球智慧吸入器市场价值将达到 184 亿美元，到 2033 年将达到 919 亿美元，2025 年至 2033 年的复合年增长率为 19.6%。

全球慢性呼吸系统疾病 (CRD) 盛行率的上升、技术先进产品的市场发展以及医疗保健领域数位解决方案的日益普及预计将促进市场的成长。

美国肺臟协会估计，到 2022 年，将有 1,170 万人（占成年人的 4.6%）被诊断出患有 COPD，这是一种包括慢性支气管炎和肺气肿的疾病。此外，世界卫生组织估计，到 2030 年，包括 COPD、肺癌和结核病在内的潜在致命呼吸道疾病将占全球死亡人数的约五分之一。

人们对智慧吸入器发展的日益关注以及主要市场参与者加强的研发力度，推动了智慧吸入器的需求。此外，越来越多的公司将数位技术融入其产品中，以提高药物疗效以及气喘和慢性阻塞性肺病（COPD）的管理。例如，2022年4月，市场参与者阿普塔製药（Aptar Pharma）推出了HeroTracker Sense，这是一款慢性呼吸道数位电子健康解决方案，可将传统的定量吸入器转换为智慧吸入器。

此外，各种研究强调了采用智慧吸入器的好处，例如帮助患者坚持治疗和控制症状，这也促进了市场的成长。例如，克利夫兰诊所2020年的一项研究发现，使用Propeller智慧吸入器的慢性阻塞性肺病患者住院风险显着降低，门诊就诊次数与前一年相比减少了近35%。

此外，数位医疗技术和连网型设备的日益普及，正在提高患者依从性，实现远端监控和个人化治疗方案。蓝牙和感测器技术的集成，使医疗保健提供者能够追踪吸入器的使用情况并优化治疗效果。政府的支持性政策、日益增强的疾病管理意识以及製药公司和科技公司之间的合作，进一步推动了市场扩张。此外，向价值导向型医疗保健的转变也推动了智慧吸入器的普及。

目录

第一章调查方法与范围

第二章执行摘要

第 3 章智慧吸入器市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 产业分析
    • 使用者观点分析
    • 主要最终用户
  • 技术展望
  • 法律规范
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 产业挑战与机会分析
  • 智慧型吸入器市场分析工具
    • 波特分析
    • PESTEL分析

第四章智慧吸入器市场：类型估计和趋势分析

  • 定义和范围
  • 2024 年及 2033 年类型市占率分析
  • 细分仪表板
  • 2021-2033年智慧型吸入器市场（按类型）
    • 干粉吸入器（DPI）
    • 定量喷雾吸入器（MDI）

第五章智慧吸入器市场：适应症与趋势分析

  • 定义和范围
  • 2024年及2033年指示市占率分析
  • 细分仪表板
  • 智慧吸入器市场（按适应症），2021-2033
    • 气喘
    • COPD
    • 其他的

第六章：智慧吸入器市场：通路评估与趋势分析

  • 定义和范围
  • 2024年及2033年通路市占率分析
  • 细分仪表板
  • 2021-2033 年智慧吸入器市场（按分销管道）
    • 医院药房
    • 零售药局
    • 网路药局

第七章智慧吸入器市场：最终用途估计与趋势分析

  • 定义和范围
  • 2024年及2033年最终用途市占率分析
  • 细分仪表板
  • 2021-2033 年智慧吸入器市场（依最终用途）
    • 医院
    • 居家护理
    • 其他的

第八章智慧吸入器市场：按国家、类型、适应症、分销管道和最终用途区域进行的估计和趋势分析

  • 定义和范围
  • 2024 年及 2033 年区域市占率分析
  • 区域市场仪表板
  • 区域市场概况
  • SWOT分析
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 2024年公司市占率分析（%）
  • 公司热图分析
  • 战略地图
    • 扩张
    • 併购
    • 伙伴关係与合作
    • 新产品发布
    • 研究与开发
  • 公司简介
    • Presspart Verwaltungs GmbH.
    • Personal Air Quality Systems Pvt Ltd
    • COHERO Health Inc.（AptarGroup, Inc.）
    • Cognita Labs
    • Adherium
    • Amiko Digital Health Limited.
    • Teva Pharmaceuticals Industries Ltd.
    • Propeller Health（ResMed）
    • Novartis AG
    • Pneuma Respiratory Inc.
    • 3M
    • AireHealth, Inc.
    • FindAir Sp. z oo
Product Code: GVR-4-68039-993-1

Smart Inhalers Market Summary

The global smart inhalers market size was estimated at USD 18.4 billion in 2024 and is projected to reach USD 91.9 billion by 2033, growing at a CAGR of 19.6% from 2025 to 2033. The rising prevalence of chronic respiratory diseases (CRDs) globally, the development of technologically advanced products, and the growing adoption of digital solutions in the healthcare sector are expected to contribute to the market's growth.

According to estimates from the American Lung Association, in 2022, 11.7 million people, or 4.6% of adults, reported a diagnosis of COPD, including chronic bronchitis and emphysema. In addition, the WHO estimates that potentially fatal respiratory diseases, including COPD, lung cancer, and tuberculosis, will account for about one in five deaths worldwide by 2030.

The increasing focus on developing smart inhalers and a rise in initiatives by key market players for R&D efforts drive the demand for smart inhalers. In addition, more companies are integrating digital technologies into their product offerings to enhance medication effectiveness and the management of asthma and COPD. For instance, in April 2022, Aptar Pharma, a market player, introduced HeroTracker Sense, a chronic respiratory digital e-health solution that converts a conventional metered dose inhaler into a smart inhaler.

Moreover, various research studies highlighting the benefits of adopting smart inhalers, such as assisting patients in treatment adherence and controlling symptoms, also contribute to the market growth. For instance, a 2020 Cleveland Clinic study discovered that patients with COPD using the Propeller company's smart inhalers had a noticeably lower risk of being admitted to the hospital, with a nearly 35% drop in visits compared to the prior year.

Furthermore, increasing adoption of digital health technologies and connected devices is enabling better patient adherence, remote monitoring, and personalized treatment plans. Integration of Bluetooth and sensor-based technologies allows healthcare providers to track inhaler usage and optimize therapy outcomes. Supportive government initiatives, growing awareness about disease management, and collaborations between pharmaceutical companies and tech firms are further accelerating market expansion. In addition, the shift toward value-based care is encouraging the adoption of smart inhalers.

Global Smart Inhalers Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global smart inhalers market report based on type, indication, distribution channel, end use, and region.

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Dry Powdered Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Asthma
  • COPD
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Homecare Settings
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Indication Outlook
    • 2.2.3. Distribution Channel Outlook
    • 2.2.4. End Use Outlook
    • 2.2.5. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Smart Inhalers Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Industry Analysis
    • 3.2.1. User Perspective Analysis
    • 3.2.2. Key End Users
  • 3.3. Technology Outlook
  • 3.4. Regulatory Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market Drivers Analysis
      • 3.5.1.1. Rising prevalence of respiratory diseases
      • 3.5.1.2. Development of technologically advanced solutions
      • 3.5.1.3. Growing adoption of digital health technologies
    • 3.5.2. Market Restraints Analysis
      • 3.5.2.1. Higher cost than traditional inhalers
    • 3.5.3. Industry Challenges and Opportunity Analysis
  • 3.6. Smart Inhalers Market Analysis Tools
    • 3.6.1. Porter's Analysis
      • 3.6.1.1. Bargaining power of the suppliers
      • 3.6.1.2. Bargaining power of the buyers
      • 3.6.1.3. Threats of substitution
      • 3.6.1.4. Threats from new entrants
      • 3.6.1.5. Competitive rivalry
    • 3.6.2. PESTEL Analysis
      • 3.6.2.1. Political landscape
      • 3.6.2.2. Economic and Social landscape
      • 3.6.2.3. Technological landscape
      • 3.6.2.4. Environmental landscape
      • 3.6.2.5. Legal landscape

Chapter 4. Smart Inhalers Market: Type Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Type Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Smart Inhalers Market: By Type, 2021 to 2033
    • 4.4.1. Dry Powdered Inhalers (DPIs)
      • 4.4.1.1. Dry Powdered Inhalers (DPIs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.4.2. Metered Dose Inhalers (MDIs)
      • 4.4.2.1. Metered Dose Inhalers (MDIs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Smart Inhalers Market: Indication Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Indication Market Share Analysis, 2024 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Smart Inhalers Market: By Indication, 2021 to 2033
    • 5.4.1. Asthma
      • 5.4.1.1. Asthma Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 5.4.2. COPD
      • 5.4.2.1. COPD Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 5.4.3. Others
      • 5.4.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Smart Inhalers Market: Distribution Channel Estimates& Trend Analysis

  • 6.1. Definition and Scope
  • 6.2. Distribution Channel Market Share Analysis, 2024 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Smart Inhalers Market: By Distribution Channel, 2021 to 2033
    • 6.4.1. Hospital Pharmacies
      • 6.4.1.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 6.4.2. Retail Pharmacies
      • 6.4.2.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 6.4.3. Online Pharmacies
      • 6.4.3.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Smart Inhalers Market: End Use Estimates& Trend Analysis

  • 7.1. Definition and Scope
  • 7.2. End Use Market Share Analysis, 2024 & 2033
  • 7.3. Segment Dashboard
  • 7.4. Smart Inhalers Market: By End Use, 2021 to 2033
    • 7.4.1. Hospital
      • 7.4.1.1. Hospital Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.2. Homecare Settings
      • 7.4.2.1. Homecare Settings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.3. Others
      • 7.4.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Smart Inhalers Market: Regional Estimates & Trend Analysis by Country, Type, Indication, Distribution Channel, End Use

  • 8.1. Definition and Scope
  • 8.2. Regional Market Share Analysis, 2024 & 2033
  • 8.3. Regional Market Dashboard
  • 8.4. Regional Market Snapshot
  • 8.5. SWOT Analysis
    • 8.5.1. North America
    • 8.5.2. Europe
    • 8.5.3. Asia Pacific
    • 8.5.4. Latin America
    • 8.5.5. Middle East & Africa
  • 8.6. Smart Inhalers Market Share, By Region, 2024 & 2033 (USD Billion)
  • 8.7. North America
    • 8.7.1. North America Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.2. U.S.
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. U.S. Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.3. Canada
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Canada Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.4. Mexico
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.4.3. Competitive Insights
      • 8.7.4.4. Mexico Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.8. Europe
    • 8.8.1. Europe Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.2. UK
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. UK Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.3. Germany
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Germany Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.4. France
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. France Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.5. Italy
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. Italy Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.6. Spain
      • 8.8.6.1. Key Country Dynamics
      • 8.8.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.6.3. Competitive Insights
      • 8.8.6.4. Spain Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.7. Sweden
      • 8.8.7.1. Key Country Dynamics
      • 8.8.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.7.3. Competitive Insights
      • 8.8.7.4. Sweden Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.8. Denmark
      • 8.8.8.1. Key Country Dynamics
      • 8.8.8.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.8.3. Competitive Insights
      • 8.8.8.4. Denmark Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.9. Norway
      • 8.8.9.1. Key Country Dynamics
      • 8.8.9.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.9.3. Competitive Insights
      • 8.8.9.4. Norway Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.9. Asia Pacific
    • 8.9.1. Asia Pacific Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.9.2. China
      • 8.9.2.1. Key Country Dynamics
      • 8.9.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.2.3. Competitive Insights
      • 8.9.2.4. China Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.9.3. Japan
      • 8.9.3.1. Key Country Dynamics
      • 8.9.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.3.3. Competitive Insights
      • 8.9.3.4. Japan Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.9.4. India
      • 8.9.4.1. Key Country Dynamics
      • 8.9.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.4.3. Competitive Insights
      • 8.9.4.4. India Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.9.5. South Korea
      • 8.9.5.1. Key Country Dynamics
      • 8.9.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.5.3. Competitive Insights
      • 8.9.5.4. South Korea Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.9.6. Australia
      • 8.9.6.1. Key Country Dynamics
      • 8.9.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.6.3. Competitive Insights
      • 8.9.6.4. Australia Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.9.7. Thailand
      • 8.9.7.1. Key Country Dynamics
      • 8.9.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.7.3. Competitive Insights
      • 8.9.7.4. Thailand Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.10. Latin America
    • 8.10.1. Latin America Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.10.2. Brazil
      • 8.10.2.1. Key Country Dynamics
      • 8.10.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.2.3. Competitive Insights
      • 8.10.2.4. Brazil Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.10.3. Argentina
      • 8.10.3.1. Key Country Dynamics
      • 8.10.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.3.3. Competitive Insights
      • 8.10.3.4. Argentina Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.11. Middle East and Africa
    • 8.11.1. Middle East and Africa Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.11.2. South Africa
      • 8.11.2.1. Key Country Dynamics
      • 8.11.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.2.3. Competitive Insights
      • 8.11.2.4. South Africa Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.11.3. Saudi Arabia
      • 8.11.3.1. Key Country Dynamics
      • 8.11.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.3.3. Competitive Insights
      • 8.11.3.4. Saudi Arabia Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.11.4. UAE
      • 8.11.4.1. Key Country Dynamics
      • 8.11.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.4.3. Competitive Insights
      • 8.11.4.4. UAE Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.11.5. Kuwait
      • 8.11.5.1. Key Country Dynamics
      • 8.11.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.5.3. Competitive Insights
      • 8.11.5.4. UAE Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Market Share Analysis, 2024 (%)
  • 9.4. Company Heat Map Analysis
  • 9.5. Strategy Mapping
    • 9.5.1. Expansion
    • 9.5.2. Mergers & Acquisition
    • 9.5.3. Partnerships & Collaborations
    • 9.5.4. New Product Launches
    • 9.5.5. Research And Development
  • 9.6. Company Profiles
    • 9.6.1. Presspart Verwaltungs GmbH.
      • 9.6.1.1. Participant's Overview
      • 9.6.1.2. Financial Performance
      • 9.6.1.3. Product Benchmarking
      • 9.6.1.4. Recent Developments
    • 9.6.2. Personal Air Quality Systems Pvt Ltd
      • 9.6.2.1. Participant's Overview
      • 9.6.2.2. Financial Performance
      • 9.6.2.3. Product Benchmarking
      • 9.6.2.4. Recent Developments
    • 9.6.3. COHERO Health Inc. (AptarGroup, Inc.)
      • 9.6.3.1. Participant's Overview
      • 9.6.3.2. Financial Performance
      • 9.6.3.3. Product Benchmarking
      • 9.6.3.4. Recent Developments
    • 9.6.4. Cognita Labs
      • 9.6.4.1. Participant's Overview
      • 9.6.4.2. Financial Performance
      • 9.6.4.3. Product Benchmarking
      • 9.6.4.4. Recent Developments
    • 9.6.5. Adherium
      • 9.6.5.1. Participant's Overview
      • 9.6.5.2. Financial Performance
      • 9.6.5.3. Product Benchmarking
      • 9.6.5.4. Recent Developments
    • 9.6.6. Amiko Digital Health Limited.
      • 9.6.6.1. Participant's Overview
      • 9.6.6.2. Financial Performance
      • 9.6.6.3. Product Benchmarking
      • 9.6.6.4. Recent Developments
    • 9.6.7. Teva Pharmaceuticals Industries Ltd.
      • 9.6.7.1. Participant's Overview
      • 9.6.7.2. Financial Performance
      • 9.6.7.3. Product Benchmarking
      • 9.6.7.4. Recent Developments
    • 9.6.8. Propeller Health (ResMed)
      • 9.6.8.1. Participant's Overview
      • 9.6.8.2. Financial Performance
      • 9.6.8.3. Product Benchmarking
      • 9.6.8.4. Recent Developments
    • 9.6.9. Novartis AG
      • 9.6.9.1. Participant's Overview
      • 9.6.9.2. Financial Performance
      • 9.6.9.3. Product Benchmarking
      • 9.6.9.4. Recent Developments
    • 9.6.10. Pneuma Respiratory Inc.
      • 9.6.10.1. Participant's Overview
      • 9.6.10.2. Financial Performance
      • 9.6.10.3. Product Benchmarking
      • 9.6.10.4. Recent Developments
    • 9.6.11. 3M
      • 9.6.11.1. Participant's Overview
      • 9.6.11.2. Financial Performance
      • 9.6.11.3. Product Benchmarking
      • 9.6.11.4. Recent Developments
    • 9.6.12. AireHealth, Inc.
      • 9.6.12.1. Participant's Overview
      • 9.6.12.2. Financial Performance
      • 9.6.12.3. Product Benchmarking
      • 9.6.12.4. Recent Developments
    • 9.6.13. FindAir Sp. z o.o
      • 9.6.13.1. Participant's Overview
      • 9.6.13.2. Financial Performance
      • 9.6.13.3. Product Benchmarking
      • 9.6.13.4. Recent Developments

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 North America smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 4 North America smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 5 North America smart inhalers market estimates and forecasts by distribution channel, 2021 - 2033 (USD Million)
  • Table 6 North America smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 7 U.S. smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 8 U.S. smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 9 U.S. smart inhalers market estimates and forecasts by distribution channel, 2021 - 2033 (USD Million)
  • Table 10 U.S. smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 11 Canada smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 12 Canada smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 13 Canada smart inhalers market estimates and forecasts by distribution channel, 2021 - 2033 (USD Million)
  • Table 14 Canada smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 15 Mexico smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 16 Mexico smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 17 Mexico smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 18 Mexico smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 19 Europe smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 20 Europe smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 21 Europe smart inhalers market estimates and forecasts by distribution channel, 2021 - 2033 (USD Million)
  • Table 22 Europe smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 23 UK smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 24 UK smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 25 UK smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 26 UK smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 27 Germany smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 28 Germany smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 29 Germany smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 30 Germany smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 31 France smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 32 France smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 33 France smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 34 France smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 35 Italy smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 36 Italy smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 37 Italy smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 38 Italy smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 39 Spain smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 40 Spain smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 41 Spain smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 42 Spain smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 43 Sweden smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 44 Sweden smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 45 Sweden smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 46 Sweden smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 47 Denmark smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 48 Denmark smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 49 Denmark smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 50 Denmark smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 51 Norway smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 52 Norway smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 53 Norway smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 54 Norway smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 55 Asia Pacific smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 56 Asia Pacific smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 57 Asia Pacific smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 59 Japan smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 60 Japan smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 61 Japan smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 62 Japan smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 63 China smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 64 China smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 65 China smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 66 China smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 67 India smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 68 India smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 69 India smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 70 India smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 71 Australia smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 72 Australia smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 73 Australia smart inhalers market estimates and forecasts by distribution channel, 2021 - 2033 (USD Million)
  • Table 74 Australia smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 75 South Korea smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 76 South Korea smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 77 South Korea smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 78 Thailand smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 79 Thailand smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 80 Thailand smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 81 Thailand smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 82 Latin America smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 83 Latin America smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 84 Latin America smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 85 Latin America smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 86 Brazil smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 87 Brazil smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 88 Brazil smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 89 Brazil smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 90 Argentina smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 91 Argentina smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 92 Argentina smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 93 Argentina smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 94 MEA smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 95 MEA smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 96 MEA smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 97 MEA smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 98 South Africa smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 99 South Africa smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 100 South Africa smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 101 South Africa smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 102 Saudi Arabia smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 103 Saudi Arabia smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 104 Saudi Arabia smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 105 Saudi Arabia smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 106 UAE smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 107 UAE smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 108 UAE smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 109 UAE smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)
  • Table 110 Kuwait smart inhalers market estimates and forecasts, by type, 2021 - 2033 (USD Million)
  • Table 111 Kuwait smart inhalers market estimates and forecasts, by indication, 2021 - 2033 (USD Million)
  • Table 112 Kuwait smart inhalers market estimates and forecasts, by distribution channel, 2021 - 2033 (USD Million)
  • Table 113 Kuwait smart inhalers market estimates and forecasts by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 List of Figures
  • Fig. 2 Smart Inhalers Market Segmentation
  • Fig. 3 Information Procurement
  • Fig. 4 Data Analysis Models
  • Fig. 5 Market Formulation and Validation
  • Fig. 6 Data Validating & Publishing
  • Fig. 7 Market Snapshot
  • Fig. 8 Segment Snapshot (1/2)
  • Fig. 9 Segment Snapshot (2/2)
  • Fig. 10 Competitive Landscape Snapshot
  • Fig. 11 Smart Inhalers- Market Size and Growth Prospects (USD Million)
  • Fig. 12 Smart Inhalers Market : Industry Value Chain Analysis
  • Fig. 13 Smart Inhalers Market : Market Dynamics
  • Fig. 14 Smart Inhalers Market : PORTER's Analysis
  • Fig. 15 Smart Inhalers Market : PESTEL Analysis
  • Fig. 16 Smart Inhalers Market Share by type 2024 & 2030 (USD Million)
  • Fig. 17 Smart Inhalers Market,by type: Market Share, 2024 & 2030
  • Fig. 18 Dry Powdered Inhalers (DPIs) Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 19 Metered Dose Ihalers (MDIs) Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 20 Smart Inhalers Market, by Indication: Key Takeaways
  • Fig. 21 Smart Inhalers Market, by Indication: Market Share, 2024 & 2030
  • Fig. 22 Asthma Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 23 COPD Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 24 Others Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 25 Smart Inhalers Market, by Distribution Channel: Key Takeaways
  • Fig. 26 Smart Inhalers Market, by Distribution Channel: Market Share, 2024 & 2030
  • Fig. 27 Hospital Pharmacies Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 28 Retail Pharmacies Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 29 Online Pharmacies Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 30 Smart Inhalers Market, by End Use: Key Takeaways
  • Fig. 31 Smart Inhalers Market, by End Use: Market Share, 2024 & 2030
  • Fig. 32 Hospitals Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 33 Homecare Settings Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 34 Others Market Estimates & Forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 35 Smart Inhalers Market Revenue, by Region, 2024 & 2030, (USD Million)
  • Fig. 36 Regional Marketplace: Key Takeaways
  • Fig. 37 Regional Marketplace: Key Takeaways
  • Fig. 38 North America Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Canada Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Mexico Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Europe Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 UK Smart Inhalers Market Estimates and Forecasts, 2021 - 2033) (USD Million)
  • Fig. 44 Germany Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 France Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Italy Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Spain Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Sweden Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Denmark Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Norway Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Asia Pacific Smart Inhalers Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 52 Japan Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 China Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 India Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Australia Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Thailand Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Latin America Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Brazil Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Argentina Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 MEA Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Saudi Arabia Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 UAE Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 South Africa Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Kuwait Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key Company Categorization
  • Fig. 66 Company Market Positioning
  • Fig. 67 Key Company Market Share Analysis, 2024
  • Fig. 68 Strategic Framework